CFDE Data Portal | Search CCNYL2

	Label	Description
	CCNYL2 associations Collection (Entity type)	Associations for CCNYL2_associations
	CCNYL2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CCNYL2 Gene (Entity type)	ENSG00000290445 - cyclin Y like 2 (pseudogene)
	GSE195568 palbociclib 2 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 4 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE95077 amiloride 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 9 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE238018 MXRA8 knockout MDA-MB-231 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE110709 GSK-J4 5 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273 GSE216292 palbociclib 0 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS

CCNYL2 associations

Associations for CCNYL2_associations

CCNYL2 associations.tsv

A file from IDG as part of the Harmonizome project

CCNYL2

ENSG00000290445 - cyclin Y like 2 (pseudogene)

GSE195568 palbociclib 2 v 10 human up

A Gene Set from LINCS

GSE77108 saha 4 v 7 human up

A Gene Set from LINCS

GSE95077 amiloride 1 v 0 human up

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 9 v 2 human up

A Gene Set from LINCS

GSE238018 MXRA8 knockout MDA-MB-231 3 v 2 human dn

A Gene Set from LINCS

GSE110709 GSK-J4 5 v 4 human dn

A Gene Set from LINCS

GSE216273 GSE216292 palbociclib 0 v 8 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.